UniSa - IRIS Institutional Research Information System

GIUDICE, VALENTINA
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 3.184
EU - Europa 2.065
AS - Asia 1.161
SA - Sud America 214
AF - Africa 43
Continente sconosciuto - Info sul continente non disponibili 8
OC - Oceania 8
Totale 6.683
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 3.171
IT - Italia 581
SG - Singapore 520
RU - Federazione Russa 437
DE - Germania 397
CN - Cina 273
FI - Finlandia 199
BR - Brasile 196
IE - Irlanda 124
UA - Ucraina 117
VN - Vietnam 112
TR - Turchia 66
IN - India 54
HK - Hong Kong 49
AT - Austria 42
GB - Regno Unito 37
SE - Svezia 37
CZ - Repubblica Ceca 36
KR - Corea 34
ET - Etiopia 23
NL - Olanda 20
CA - Canada 10
EG - Egitto 9
FR - Francia 9
EU - Europa 8
ID - Indonesia 8
AR - Argentina 7
BD - Bangladesh 7
JP - Giappone 7
NP - Nepal 7
AU - Australia 6
EC - Ecuador 6
ES - Italia 5
PL - Polonia 5
KE - Kenya 4
PK - Pakistan 4
TH - Thailandia 4
UZ - Uzbekistan 4
JO - Giordania 3
LU - Lussemburgo 3
MK - Macedonia 3
BE - Belgio 2
DZ - Algeria 2
HR - Croazia 2
HU - Ungheria 2
LY - Libia 2
MA - Marocco 2
NZ - Nuova Zelanda 2
VE - Venezuela 2
AE - Emirati Arabi Uniti 1
AL - Albania 1
BA - Bosnia-Erzegovina 1
CH - Svizzera 1
CO - Colombia 1
GE - Georgia 1
GR - Grecia 1
HN - Honduras 1
IL - Israele 1
IQ - Iraq 1
IR - Iran 1
KZ - Kazakistan 1
LK - Sri Lanka 1
MD - Moldavia 1
MX - Messico 1
MY - Malesia 1
NI - Nicaragua 1
PE - Perù 1
PH - Filippine 1
PY - Paraguay 1
RS - Serbia 1
SI - Slovenia 1
SN - Senegal 1
Totale 6.683
Salva come PNG Salva come JPEG
Città #
Ann Arbor 465
Chandler 453
Woodbridge 326
Princeton 305
Munich 275
Ashburn 249
Singapore 191
Wilmington 188
Houston 156
Jacksonville 147
Helsinki 142
Naples 117
Dong Ket 112
Dublin 108
Moscow 88
Salerno 63
Andover 57
Beijing 56
Izmir 56
Nuremberg 56
Hong Kong 44
Boardman 43
Brno 36
Redwood City 35
Rome 35
Nanjing 34
Washington 33
Los Angeles 28
Addis Ababa 23
Pellezzano 23
Pune 23
Dallas 19
Milan 19
Düsseldorf 18
Fairfield 18
Fisciano 18
Vienna 18
Changsha 17
Jyväskylä 17
Norwalk 14
Seattle 14
Rio de Janeiro 13
São Paulo 13
Lappeenranta 12
Nanchang 12
Amsterdam 11
Guangzhou 11
Tianjin 11
Belo Horizonte 10
Manchester 9
Cambridge 8
Cava de' Tirreni 8
Domicella 8
Shenyang 8
Caserta 7
Catania 7
Kathmandu 7
Richmond 7
Shanghai 7
Curitiba 6
Dearborn 6
Pisa 6
San Prisco 6
Santa Clara 6
Toronto 6
West Jordan 6
Cava De' Tirreni 5
Council Bluffs 5
Edinburgh 5
Fort Worth 5
Jiaxing 5
Mercato San Severino 5
Napoli 5
Piacenza 5
Quito 5
Rochester 5
San Diego 5
Turin 5
Zhengzhou 5
Bologna 4
Brasília 4
Cairo 4
Cellole 4
Chiang Mai 4
Hebei 4
Hefei 4
Juiz de Fora 4
Lentini 4
London 4
Madrid 4
Menlo Park 4
Nairobi 4
Palermo 4
Pescara 4
Teano 4
Tongling 4
Triggiano 4
Wenzhou 4
Al Maḩallah al Kubrá 3
Amman 3
Totale 4.497
Salva come PNG Salva come JPEG
Nome #
Involvement of soluble forms of receptor of the urokinase-type plasminogen activator (UPAR) in hematopoietic stem cell homing 249
Post-therapy B regulatory cells might early predict relapse in Hodgkin lymphoma 168
Giant plasma cells with multiple immature nuclei in a young woman with newly diagnosed multiple myeloma 167
Autologous And Allogeneic Stem Cell Transplantation Is Associated With Long-Lasting Endocrine Disorders 134
Lenalidomide-Mediated NK Cells Expansion In Elderly Multiple Myeloma Patients 132
High incidence of cytomegalovirus reactivation in patients with lymphoma treated with bendamustine 132
Accelerated and persistent bone loss after autologous and allogeneic stem cell transplantation 128
Continuous maintenance therapy with alternate-day low dose lenalidomide in multiple myeloma patients after autologous stem cell transplantation increases the number of circulating natural killer cells 124
Anaplastic CD30+ alk- (micro) lymphoma arising out of mediastinal Plasma Cell Castleman’s disease in immunocompetent patient treated by rituximab- dexametasone and continuous lenalidomide 119
Prolonged low-dose lenalidomide treatment increases the number of circulating natural killer cells in multiple mieloma patients 112
Prophylactic therapy with oral low-dose valgancyclovir in cytomegalovirus-positive allogeneic stem cell transplant recipients 107
Prolonged azacitidine treatment in the management of elderly patients with high risk myelodysplastic syndromes, chronic myelomonocytic leukemia and acute myeloid leukemia not eligible for standard intensive therapy 106
Induction therapy with continuous alternate-day low dose lenalidomide combined with low-dose prednisone in octogenarian Multiple Myeloma patients 105
Efficacy and safety of splenectomy in adult autoimmune hemolytic anemia. 100
Cytomegalovirus reactivation prophylaxis with low dose valgancyclovir after hematopoietic stem cell transplantation 98
67 KDA laminin receptor (67LR) in normal and neoplastic hematopoietic cells: is its targeting a feasible approach? 98
Daily low-dose valgancyclovir is safe and effective CMV-reactivation prophylaxis in HLA-identical sibling hematopoietic stem cell transplantation. Bone Marrow Transplantation 97
Continuous maintenance therapy with alternate-day low dose lenalidomide in multiple myeloma patients after autologous stem cell transplantation 95
Urokinase type plasminogen activator receptor (UPAR) as a new therapeutic target in cancer. 93
Endocrine disorders after autologous and allogeneic stem cell transplantation 91
Flow Cytometric Detection Of B-cell Membrane Markers CD5, CD11c, CD20, CD38 And CD49d May Predict Outcome In Chronic Lymphocytic Leukemia And Non-Hodgkin Lymphoma 91
Bone marrow mesenchymal stem cells as a possible ruxolitinib reservoir in the bone marrow niche 89
In vitro apoptotic effects of farnesyltransferase blockade in acute myeloid leukemia cells. 86
Sirt-1 as a novel therapeutic target for improving nitric oxide release in heterozygous and homozygous patients for mthfr mutations 85
Aplastic anemia: Pathophysiology 84
Endocrinopathies after allogeneic and autologous transplantation of hematopoietic stem cells. 83
Prolonged complete hematologic response in relapsed/refractory T-large granular lymphocyte leukemia after bendamustine treatment. 81
Reproductive issues in patients undergoing Hematopoietic Stem Cell Transplantation: an update 76
Role of Laparoscopic Splenectomy in Elderly Immune Thrombocytopenia. 76
Combined liposomal amphotericin b and surgery as successful management for pulmunary mucormycosis in a patient with acute myeloid leukemia 72
Therapeutic drug monitoring might identify poor responders to ruxolitinib treatment in myeloproliferative neoplasms 71
Low-dose valgancyclovir as cytomegalovirus reactivation prophylaxis in allogeneic hematopoietic stem cell transplantation 67
Real-world evidence of cytomegalovirus reactivation in non-Hodgkin lymphomas treated with bendamustine-containing regimens 67
Low-dose valgancyclovir as cytomegalovirus reactivation prophylaxis in allogeneic haematopoietic stem cell transplantation. 65
Effects of selected preanalytical variables on Dried Blood Spot (DBS) and Volumetric Adsorptive Microsampling (VAMS) based bioanalytical methods for the determination of four β-lactam antibiotics 64
Aptamers and Antisense Oligonucleotides for Diagnosis and Treatment of Hematological Diseases 64
3D Biomimetic Scaffold for Growth Factor Controlled Delivery: An in-vitro study of Tenogenic events on Wharton’s Jelly Mesenchymal stem cells 63
Bone Marrow Failure Syndromes, Overlapping Diseases with a Common Cytokine Signature 61
Daily low-dose valgancyclovir is safe and effective CMV-reactivation prophylaxis in HLA-identical sibling hematopoietic stem cell transplantation 59
Combination of Ruxolitinib and Eculizumab for Treatment of Severe SARS-CoV-2-Related Acute Respiratory Distress Syndrome: A Controlled Study 58
Successful management of pulmonary mucormycosis with liposomal amphotericin B and surgery treatment: a case report 55
Immunohistochemical algorithms and gene expression profiling in primary cutaneous B-cell lymphoma 54
How to Improve the Definition of Chronic Lymphocytic Leukemia Outcome Using a Simple Flow Cytometric Score Based on CD49d and Homing Marker Expression 53
Real-world experience with the Sydney System on 1458 cases of lymph node fine needle aspiration cytology 53
Can we turn off the “Covid-biting-tail” inflammation? 51
Stem cell and macrophage roles in skeletal muscle regenerative medicine 51
Gender Differences in the Impact of COVID-19 Pandemic on Mental Health of Italian Academic Workers 51
Axitinib in Ponatinib-Resistant B-Cell Acute Lymphoblastic Leukemia Harboring a T315L Mutation 50
Identification of uPAR Variants Acting as ceRNAs in Leukaemia Cells 50
SIRT1 pharmacological activation rescues vascular dysfunction and prevents thrombosis in MTHFR deficiency 48
A simple flow cytometric score based on CD49d and homing marker expression in chronic lymphocytic leukemia (CLL). 47
Pharmacogenetics of Carbamazepine and Valproate: Focus on Polymorphisms of Drug Metabolizing Enzymes and Transporters 47
Mucosal-Associated Invariant T Cells in T-Cell Non-Hodgkin Lymphomas: A Case Series 46
OPSI threat in hematological patients 46
Myogenic commitment of human stem cells by myoblasts Co-culture: a static vs. a dynamic approach 45
Aptamer-based proteomics of serum and plasma in acquired aplastic anemia 43
A case series of blastic plasmacytoid dendritic cell neoplasia 43
Abnormal RNA splicing and genomic instability after induction of DNMT3A mutations by CRISPR/Cas9 gene editing 41
WT1 Expression Levels Combined with Flow Cytometry Blast Counts for Risk Stratification of Acute Myeloid Leukemia and Myelodysplastic Syndromes 41
Chondrogenic Commitment of human Bone Marrow Mesenchymal Stem Cells in a perfused, hTGF-β1-releasing PLGA microcarrier seeded, collagen hydrogel 40
Prophylactic letermovir decreases cytomegalovirus reactivation after stem cell transplantation: a single-center real-world evidence study 39
Electrophysiological Studies in Combination With Interim-Positron Emission Tomography Scan for Prevention of Severe Brentuximab-Vedotin-Induced Neurotoxicity 38
The Role of B Regulatory Cells in the Immunological Escape of Tumor Cells in Hodgkin Lymphoma 37
Post-Transplant Cyclophosphamide (PTCY) as GVHD Prophylaxis for Hematopoietic Stem Cell Transplantation From Matched-Related Sibling Donors 37
3D in-vitro cultures of human bone marrow and Wharton’s jelly derived mesenchymal stromal cells show high chondrogenic potential 36
Single Cell RNA Sequencing and V(D)J Profiling of T-Cell Large Granular Lymphocytosis. 36
Peripheral blood mononuclear cells contribute to myogenesis in a 3D bioengineered system of bone marrow mesenchymal stem cells and myoblasts 35
Lenalidomide-induced psoriasis in a refractory multiple myeloma patient successfully treated with narrowband ultraviolet B 34
Pharmacovigilance of Selective Serotonin Reuptake Inhibitors and Gender Differences in Stroke Incidence 34
Lymph node fine-needle cytology in the era of personalised medicine. Is there a role? 34
Reduced Proliferative Potential with Conserved Stem/Stromal Phenotype of Human Umbilical Cord Mesenchymal Stem Cells in Placental Syndromes: A Prospective Cohort Study 33
Sex-tailored pharmacology and COVID-19: next steps towards appropriateness and health equity 33
High throughput pSTAT signaling profiling by fluorescent cell barcoding and computational analysis 32
Cardiotoxicity of Novel Targeted Hematological Therapies 32
Non-invasive prenatal test identifies circulating cell-free DNA chromosomal abnormalities derived from clonal hematopoiesis in aggressive hematological malignancies 31
Hemopoiesis and Immune Cell Perturbations during Venetoclax Plus Azacytidine Treatment in Acute Myeloid Leukemia 31
Fluorescent Cell Barcoding for Immunophenotyping 31
Eltrombopag monotherapy can improve hematopoiesis in patients with low to intermediate risk-1 myelodysplastic syndrome 31
Inter-intra instrument comparison and standardization of a 10-color immunophenotyping for B and T cell non-Hodgkin lymphoma diagnosis and monitoring 29
Implementation of International Prognostic Index with flow cytometry immunophenotyping for better risk stratification of chronic lymphocytic leukemia 28
Single-cell RNA sequencing coupled to TCR profiling of large granular lymphocyte leukemia T cells 28
Kaposi's sarcoma associated with chronic myeloid leukemia and imatinib mesylate therapy 28
Stem Cells from Healthy and Tendinopathic Human Tendons: Morphology, Collagen and Cytokines Expression and Their Response to T3 Thyroid Hormone 28
Efficacy of Decitabine and Venetoclax as Salvage and Bridge Therapy to Haploidentical Hematopoietic Stem Cell Transplantation in a Multiresistant Acute Myeloid Leukemia Patient 27
Low-Density Granulocytes Are Decreased in Acute Myeloid Leukemia and in Myelodysplastic Syndromes with Negative Prognostic Factors 27
A Frail Hairy Cell Leukemia Patient Successfully Treated with Pegylated Interferon-α-2A 27
SERUM FREE LIGHT CHAIN RATIO AS A BIOMARKER OF MULTIPLE MYELOMA PROGRESSION AND ASSOCIATED RENAL DISEASE 27
Persistent decreased bone marrow CD3+CD56+ T lymphocytes are inversely associated with mature granulocytes in myelodysplastic syndromes 27
Circulating exosomal microRNAs in acquired aplastic anemia and myelodysplastic syndromes 27
The value of flow cytometry clonality in large granular lymphocyte leukemia 27
Cytomegalovirus reactivation is frequent in multiple myeloma patients treated with daratumumab-based regimens 26
Efficacy and safety of belantamab-mafodotin in triple-refractory multiple myeloma patients: A multicentric real-life experience 26
Clinical efficacy of azacytidine and venetoclax and prognostic impact of Tim-3 and galectin-9 in acute myeloid leukemia and high-risk myelodysplastic syndromes: A single-center real-life experience 26
Eltrombopag Improves Hematopoiesis in Patients with Low to Intermediate-2 Risk Myelodysplastic Syndrome (MDS). 26
Serum Free Light-Chain Ratio at Diagnosis Is Associated with Early Renal Damage in Multiple Myeloma: A Case Series Real-World Study 25
c-Kit M541L variant is related to ineffective hemopoiesis predisposing to clonal evolution in 3D in vitro biomimetic co-culture model of bone marrow niche 25
Sicurezza del vaccino ricombinante anti-herpes Zoster virus in popolazioni fragili: uno studio osservzionale 25
Gender Differences in Levodopa Pharmacokinetics in Levodopa-Naïve Patients With Parkinson's Disease 24
INTENSIFICATION AND MAINTENANCE WITH RITUXIMAB IN PATIENTS WITH DLBCL IN UNCERTAIN CR OR PR (PET-ORIENTED) AFTER INDUCTION THERAPY WITH R-CHOP OR SIMILAR THERAPIES; OUR EXPERIENCE 23
Multiple myeloma characteristics correlated to serum free light chain ratio at diagnosis and association with early renal damage 23
Totale 6.065
Salva come PNG Salva come JPEG
Categoria #
all - tutte 32.199
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 32.199
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/202063 0 0 0 0 0 0 0 0 0 0 51 12
2020/2021514 10 29 25 2 103 28 42 11 29 39 58 138
2021/2022569 14 2 14 43 16 15 4 17 72 46 75 251
2022/20231.182 94 108 85 129 111 209 54 122 155 4 58 53
2023/2024921 77 90 73 59 71 162 71 71 17 40 53 137
2024/20252.176 76 36 42 84 173 277 662 249 447 122 8 0
Totale 6.961